RBC Capital lowered the firm’s price target on Evotec (EVO) to EUR 10 from EUR 11.20 and keeps an Outperform rating on the shares.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVO:
- Evotec SE Launches Share Repurchase Program to Enhance Shareholder Value
- Evotec announces up to EUR 3M share repurchase program
- Evotec AG: Strategic Growth Potential Amid Market Challenges Justifies Buy Rating
- Evotec AG Reports Strategic Shift Amid Mixed Performance
- Evotec AG Earnings Call: Resilience Amidst Challenges